Literature DB >> 18726715

Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis.

Derek Holmes1, Qi Jiang, Liguo Zhang, Lishan Su.   

Abstract

FoxP3(+)CD4(+)CD25(+) regulatory T (Treg) cells are implicated in a number of pathologic processes including elevated levels in cancers and infectious diseases, and reduced levels in autoimmune diseases. Treg cells are activated to modulate immune responses to avoid over-reactive immunity. However, conflicting findings are reported regarding relative levels of Treg cells during HIV-1 infection and disease progression. The role of Treg cells in HIV-1 diseases (aberrant immune activation) is poorly understood due to lack of a robust model. We summarize here the regulation and function of Foxp3 in Treg cells and in modulating HIV-1 replication. Based on recent findings from SIV/monkey and HIV/humanized mouse models, a model of the dual role of Treg cells in HIV-1 infection and immuno-pathogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726715      PMCID: PMC3971055          DOI: 10.1007/s12026-008-8037-x

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  135 in total

1.  Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

Authors:  J E Merrill; Y Koyanagi; I S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

2.  The scid mutation in mice causes a general defect in DNA repair.

Authors:  G M Fulop; R A Phillips
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

3.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

4.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

5.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

6.  Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.

Authors:  T Lapidot; F Pflumio; M Doedens; B Murdoch; D E Williams; J E Dick
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

Review 7.  SCID mouse models of human stem cell engraftment.

Authors:  D L Greiner; R A Hesselton; L D Shultz
Journal:  Stem Cells       Date:  1998       Impact factor: 6.277

8.  Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.

Authors:  P Rieckmann; G Poli; C H Fox; J H Kehrl; A S Fauci
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

9.  Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes.

Authors:  Z Smit-McBride; J J Mattapallil; M McChesney; D Ferrick; S Dandekar
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

Authors:  G R Kaufmann; P Cunningham; A D Kelleher; J Zaunders; A Carr; J Vizzard; M Law; D A Cooper
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  26 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.

Authors:  Tanya O Robinson; Mingce Zhang; Christina Ochsenbauer; Lesley E Smythies; Randall Q Cron
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

3.  Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 4.  Signalling through FOXP3 as an X-linked tumor suppressor.

Authors:  Hiroto Katoh; Pan Zheng; Yang Liu
Journal:  Int J Biochem Cell Biol       Date:  2010-08-01       Impact factor: 5.085

Review 5.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

6.  Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.

Authors:  Rui Wang; Lina Kozhaya; Frances Mercer; Alka Khaitan; Hodaka Fujii; Derya Unutmaz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

7.  Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate-Dependent Mechanisms in Humanized Mice In Vivo.

Authors:  Guangming Li; Jun-Ichi Nunoya; Liang Cheng; Natalia Reszka-Blanco; Li-Chung Tsao; Jerry Jeffrey; Lishan Su
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

8.  Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV.

Authors:  G Degaffe; R Zakhour; W Zhang; G A Contreras; C S Bell; G Rodriguez; G Del Bianco; N Pérez; L J Benjamins; J R Murphy; G P Heresi; D Q Tran
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

9.  Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Alison E Hogg; Thorsten Demberg; Katherine McKinnon; David Venzon; Egidio Brocca-Cofano; Janet Dipasquale; Eun M Lee; Lauren Hudacik; Ranajit Pal; Yongjun Sui; Jay A Berzofsky; Linda Liu; Solomon Langermann; Marjorie Robert-Guroff
Journal:  Virology       Date:  2013-10-09       Impact factor: 3.616

10.  Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency.

Authors:  Michelle M Miller; Jonathan E Fogle; Peter Ross; Mary B Tompkins
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-01       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.